Milind S. Deshpande's most recent trade in Spero Therapeutics Inc was a trade of 20,000 Common Stock done . Disclosure was reported to the exchange on May 29, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Spero Therapeutics Inc | Milind S. Deshpande | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2024 | 20,000 | 71,454 (0%) | 0% | 0 | Common Stock | |
Spero Therapeutics Inc | Milind S. Deshpande | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Sep 2022 | 15,000 | 31,454 (0%) | 0% | 0 | Common Stock | |
Spero Therapeutics Inc | Milind S. Deshpande | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Aug 2021 | 7,500 | 7,500 | - | - | Stock Option (right to buy) | |
Spero Therapeutics Inc | Milind S. Deshpande | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2021 | 2,629 | 2,629 | - | - | Stock Option (right to buy) | |
Spero Therapeutics Inc | Milind S. Deshpande | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Oct 2020 | 7,500 | 7,500 | - | - | Stock Option (right to buy) |